Tethys BioScience
Biological Markers for Diagnoses
Tethys BioScience, Inc. engages in the discovery, development, and commercialization of biological markers. Its products are used to diagnosis the metabolic diseases, such as diabetes. The company offers PreDx Diabetes Risk Test, a diagnostic test...Founded in 2002
Homepage: http://www.tethysbio.com
Total money raised: $30.4M
94608
5858 Horton Street
Suite 550
Emeryville
USA CA
Suite 550
Emeryville
USA CA
Phone: 510-420-6700
Updated on May 6, 2013
Tethys BioScience at CrunchBase
Dr .Urdea Founder & Chief Executive OfficerTethys BioScience at CrunchBase
Mickey S. Urdea Co - Founder
Randy Strahan President & Chief Executive Officer & Board Member
David Hodgson Chief Information Officer
John Hollister Senior Vice President, Marketing
R. Michael Richey President
Caitlyn Waller Krebs Director, Business Development
Frances Chin Lee Director, Clinical Lab Operations
Steve Eichenlaub Board Member
Lawrence Leisure Board Member
Gregory T. Went Board Member
Juan P. Frias Chief Medical Officer
Mani Grewal Director, Informatics Operations
Brook Byers Board Member
Bill Ericson Board Member
George Rehm Board Member
Past
November, 2009
Tethys BioScience raised $25M in a Series D round from Aeris Capital, Wasatch Advisors, Intel Capital, Kleiner Perkins Caufield & Byers, and Mohr Davidow Ventures
Tethys picks up $25M for diabetes diagnostic 
deals.venturebeat.com
September, 2008
Tethys BioScience acquired Lipomics Technologies
Tethys Bioscience Announces Acquisition of Lipomics Technologies 
lipomics.com
October, 2005
Tethys BioScience raised $5.4M in a Series A round from Mohr Davidow Ventures
2002
Tethys BioScience was founded in 2002